Lv1
78 积分 2022-05-20 加入
KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer
13小时前
已完结
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer
1个月前
已完结
Farnesylation-driven KRAS phase separation promotes colon tumor growth
1个月前
已完结
Pearling drives mitochondrial DNA nucleoid distribution
6个月前
已完结
Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma
10个月前
已关闭
T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer
1年前
已完结
Combined KRAS inhibition and immune therapy generates durable complete responses in an autochthonous PDAC model
1年前
已完结
The liver casts a wide NET for metastatic pancreatic cancer
1年前
已完结
Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer
1年前
已完结
FABP4-tastic Pancreatic Stellate Cells Coddle KITL to Uphold Inherent Microenvironmental Tumor Suppression
1年前
已完结
皖公网安备34019202002308
